MiR-942 Mediates Hepatitis C Virus-Induced Apoptosis via Regulation of ISG12a
Open Access
- 11 April 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (4) , e94501
Abstract
The interaction between hepatitis C virus (HCV) and human hepatic innate antiviral responses is unclear. The aim of this study was to examine how human hepatocytes respond to HCV infection. An infectious HCV isolate, JFH1, was used to infect a newly established human hepatoma cell line HLCZ01. Viral RNA or NS5A protein was examined by real-time PCR or immunofluorescence respectively. The mechanisms of HCV-induced IFN-β and apoptosis were explored. Our data showed that HLCZ01 cells supported the entire HCV lifecycle and IFN-β and interferon-stimulated genes (ISGs) were induced in HCV-infected cells. Viral infection caused apoptosis of HLCZ01 cells. Silencing of RIG-I, IRF3 or TRAIL inhibited ISG12a expression and blocked apoptosis of viral-infected HLCZ01 cells. Knockdown ISG12a blocked apoptosis of viral-infected cells. MiR-942 is a candidate negative regulator of ISG12a predicted by bioinformatics search. Moreover, HCV infection decreased miR-942 expression in HLCZ01 cells and miR-942 was inversely correlated with ISG12a expression in both HCV-infected cells and liver biopsies. MiR-942 forced expression in HLCZ01 cells decreased ISG12a expression and subsequently suppressed apoptosis triggered by HCV infection. Conversely, silencing of miR-942 expression by anti-miR-942 increased ISG12a expression and enhanced apoptosis in HCV-infected cells. Induction of Noxa by HCV infection contributed to ISG12a-mediated apoptosis. All the data indicated that innate host response is intact in HCV-infected hepatocytes. MiR-942 regulates HCV-induced apoptosis of human hepatocytes by targeting ISG12a. Our study provides a novel mechanism by which human hepatocytes respond to HCV infection.Keywords
This publication has 34 references indexed in Scilit:
- Inhibition of Hepatitis C Virus Infection by DNA Aptamer against Envelope ProteinAntimicrobial Agents and Chemotherapy, 2013
- Regulation of hepatic innate immunity by hepatitis C virusNature Medicine, 2013
- 2-Octynoic Acid Inhibits Hepatitis C Virus Infection through Activation of AMP-Activated Protein KinasePLOS ONE, 2013
- Involvement of Noxa in Cellular Apoptotic Responses to Interferon, Double-stranded RNA, and Virus InfectionJournal of Biological Chemistry, 2005
- Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-IJournal of Virology, 2005
- Understanding hepatitis C.2004
- Gene Expression Associated With Interferon Alfa Antiviral Activity in An Hcv Replicon Cell LineHepatology, 2003
- Interleukin-1 Inhibits Hepatitis C Virus Subgenomic RNA Replication by Activation of Extracellular Regulated Kinase PathwayJournal of Virology, 2003
- Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA ReplicationJournal of Virology, 2002
- Binding of Hepatitis C Virus to CD81Science, 1998